BioSig Technologies, Inc.
12424 Wilshire Blvd., Suite 745
Los Angeles, California 90025
June 20, 2019
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Securities and Exchange Commission
Washington, D.C. 20549
Attention: Tim Buchmiller
Re: BioSig Technologies, Inc.
Registration Statement on Form S-3, filed on May 31, 2019
File No. 333-231862(the “Registration Statement”)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioSig Technologies, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 9:00 a.m., Eastern Time, on June 24, 2019, or as soon thereafter as practicable.
| Very truly yours,
BIOSIG TECHNOLOGIES, INC. | ||||||
| By: | /s/ Kenneth Londoner | ||||||
| Kenneth Londoner Chief Executive Officer | |||||||
cc: Rick A. Werner, Esq., Haynes and Boone, LLP
